Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology (Q34379865)

1 August 2017

1 reference

title

Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology (English)

1 reference

1 August 2017

1 reference

pulmonary hypertension

1 reference

Walsh MC

1

1 reference

1 August 2017

Stork EK

series ordinal

2

1 reference

1 August 2017

language of work or name

1 reference

1 September 2001

1 reference

1 August 2017

published in

Clinics in Perinatology

1 reference

1 August 2017

volume

28

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

609-27, vii

1 reference

Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Hidden mortality rate associated with extracorporeal membrane oxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

The release of a bradykinin-like pulmonary vasodilator substance in foetal and new-born lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Misalignment of lung vessels and alveolar capillary dysplasia: a cause of persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Persistent pulmonary hypertension in the neonate: Diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Bradykinin produces pulmonary vasodilation in fetal lambs: role of prostaglandin production

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

The structural basis of PPHN.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Neonatal hypoxia and pulmonary vasospasm: Response to tolazoline

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Generation of prostacyclin by lungs in vivo and its release into the arterial circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Prostanoids in neonates with persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Adaptation of the pulmonary circulation to extra-uterine life in the pig and its relevance to the human infant.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Congenital Alveolar Capillary Dysplasia—An Unusual Cause of Respiratory Distress in the Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Long-term neurophysiologic outcome after neonatal extracorporeal membrane oxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Alkalosis attenuates hypoxic pulmonary vasoconstriction in neonatal lambs.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

The structural basis of persistent pulmonary hypertension of the newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

The Third Grover Conference on the pulmonary Circulation. The control of cellular proliferation in the pulmonary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Structure and function in pulmonary hypertension. New perceptions

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Increased arterial pH, not decreased PaCO2, attenuates hypoxia-induced pulmonary vasoconstriction in newborn lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Persistent Pulmonary Hypertension of the Newborn: Role of Nitric Oxide and Endothelin in Pathophysiology and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Misalignment of lung vessels: a syndrome causing persistent neonatal pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

Nitric oxide and the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970109-3

7 January 2021

10.1016/S0095-5108(05)70109-3

Identifiers

DOI

1 reference

1 August 2017

1 reference